Prenetics Stops Bitcoin Purchases but Maintains 510 BTC Holdings

Prenetics Global Shifts Focus Away from Bitcoin Purchases to Prioritize Consumer Health Brand

Prenetics Global Limited has announced a strategic pivot, discontinuing its Bitcoin treasury acquisition program to concentrate on expanding its consumer health brand, IM8. The decision marks a significant change from the company’s previous bullish stance on digital assets as part of its capital allocation.

Key Takeaways

• Prenetics has halted its Bitcoin purchasing activities to reallocate resources toward its flagship health brand, IM8.
• The company still retains 510 Bitcoin on its balance sheet, alongside over $70 million in cash and equivalents.
• Earlier this year, Prenetics invested $20 million to acquire approximately 187 Bitcoin at an average cost of $106,712 per coin.
• The move aligns with broader industry trends where companies reassess their cryptocurrency strategies amid market volatility.

Tickers mentioned: None

Sentiment: Neutral

Price impact: Negative. The cessation of Bitcoin purchases and the unrealized loss on holdings may influence investor sentiment.

Trading idea (Not Financial Advice): Hold. The company’s strategic focus on consumer health indicates a potential for stable growth outside of cryptocurrency volatility.

The Hong Kong-based company recently announced that it paused its Bitcoin buyback on December 4, shifting its primary focus towards scaling IM8, a nutritional supplement brand co-founded with former football star David Beckham. IM8 has achieved over $100 million in annualized recurring revenue within just eleven months of launch. This pivot signifies Prenetics’ increased emphasis on its core health sector, a move viewed as a strategic effort to stabilize its revenue streams.

While the company retains 510 Bitcoin on its balance sheet, its earlier investment of $20 million in Bitcoin—acquired at an average price of over $106,700—has resulted in an unrealized loss of about 17%, or roughly $3.4 million, as Bitcoin’s price currently hovers around $88,200. Despite this, Prenetics did not indicate plans to liquidate its holdings, maintaining a long-term outlook on Bitcoin appreciation.

Despite the recent pullback in its Bitcoin strategy, Prenetics’ shares declined marginally—down 3.32% on Nasdaq—although they remain up nearly 170% for the year. Industry experts note that the company’s reassessment reflects a broader trend among firms reevaluating the risks associated with cryptocurrency investments amid ongoing market volatility.

According to data from BitcoinTreasuries.NET, approximately 192 publicly traded companies now hold nearly 1.1 million Bitcoin collectively. Prominent among them is Strategy, led by Michael Saylor, which holds over 670,000 Bitcoin and has articulated confidence in Bitcoin’s long-term growth, citing expectations of prices reaching as high as $1 million per coin.

Strategy’s CFO, Andrew Kang, emphasized in a recent interview that the company’s continued Bitcoin accumulation aligns with a belief in its long-term value proposition, projecting prices will inevitably recover and advance over time. This perspective underscores the contrasting approaches within corporate crypto strategies—some leveraging Bitcoin as a treasury reserve, others shifting priorities toward core operational growth areas.